Target
Neuronal acetylcholine receptor subunit alpha-7
Ligand
BDBM50514307
Substrate
n/a
Meas. Tech.
ChEMBL_1856270 (CHEMBL4356999)
EC50
324±n/a nM
Citation
 Sinha, NKarche, NPVerma, MKWalunj, SSNigade, PBJana, GKurhade, SPHajare, AKTilekar, ARJadhav, GRThube, BRShaikh, JSBalgude, SSingh, LBMahimane, VAdurkar, SKHatnapure, GRaje, FBhosale, YBhanage, DSachchidanand, SDixit, RGupta, RBokare, AMDandekar, MBharne, AChatterjee, MDesai, SKoul, SModi, DMehta, MPatil, VSingh, MGundu, JGoel, RNShah, CSharma, SBakhle, DKamboj, RKPalle, VP Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of ?7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization. J Med Chem 63:944-960 (2020) [PubMed]  Article 
Target
Name:
Neuronal acetylcholine receptor subunit alpha-7
Synonyms:
ACHA7_HUMAN | CHRNA7 | Cholinergic, Nicotinic Alpha7 | NACHRA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | Neuronal acetylcholine receptor subunit alpha-7 (nAChR-alpha 7) | Nicotinic acetylcholine receptor alpha-7 (alpha7 nAChR)
Type:
n/a
Mol. Mass.:
56448.33
Organism:
Homo sapiens (Human)
Description:
CHRNA7 (NACHRA7)
Residue:
502
Sequence:
MRCSPGGVWLALAASLLHVSLQGEFQRKLYKELVKNYNPLERPVANDSQPLTVYFSLSLLQIMDVDEKNQVLTTNIWLQMSWTDHYLQWNVSEYPGVKTVRFPDGQIWKPDILLYNSADERFDATFHTNVLVNSSGHCQYLPPGIFKSSCYIDVRWFPFDVQHCKLKFGSWSYGGWSLDLQMQEADISGYIPNGEWDLVGIPGKRSERFYECCKEPYPDVTFTVTMRRRTLYYGLNLLIPCVLISALALLVFLLPADSGEKISLGITVLLSLTVFMLLVAEIMPATSDSVPLIAQYFASTMIIVGLSVVVTVIVLQYHHHDPDGGKMPKWTRVILLNWCAWFLRMKRPGEDKVRPACQHKQRRCSLASVEMSAVAPPPASNGNLLYIGFRGLDGVHCVPTPDSGVVCGRMACSPTHDEHLLHGGQPPEGDPDLAKILEEVRYIANRFRCQDESEAVCSEWKFAACVVDRLCLMAFSVFTIICTIGILMSAPNFVEAVSKDFA
  
Inhibitor
Name:
BDBM50514307
Synonyms:
CHEMBL4457158
Type:
Small organic molecule
Emp. Form.:
C20H18ClNO3S2
Mol. Mass.:
419.945
SMILES:
CCC(=O)c1sc(c(C)c1-c1ccc(cc1)S(N)(=O)=O)-c1ccc(Cl)cc1
Structure:
Search PDB for entries with ligand similarity: